Release Date: 29/10/10 08:25 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 2.31MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%